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Adult skeletal muscle has the striking ability to repair and
regenerate itself after injury. This would not be possible
without satellite cells, a subpopulation of cells existing
at the margin of the myofiber. Under most conditions,
satellite cells are quiescent, but they are activated in re-
sponse to trauma, enabling them to guide skeletal mus-
cle regeneration. In degenerative skeletal muscle states,
including motor nerve denervation, advanced age, atro-
phy secondary to deconditioning or immobilization, and
Duchenne muscular dystrophy, satellite cell numbers and
proliferative potential significantly decrease, contributing
to a diminution of skeletal muscle’s regenerative capac-
ity and contractility. This review will highlight the fate of
satellite cells in several degenerative conditions involv-
ing skeletal muscle, and will attempt to gauge the rel-
ative contributions of apoptosis, senescence, impaired
proliferative potential, and host factors to satellite cell
dysfunction.
Keywords: apoptosis; programmed cell death; sarcopenia;
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Introduction
Adult skeletal muscle demonstrates the remarkable ca-
pacity to adapt to trauma and injury. The processes by
which these physiologic adaptations occur are largely at-
tributed to satellite cells, a distinct population of cells at
the periphery of the myofiber, first described in 1961.1
Satellite cells are the myogenic cells responsible for post-
natal muscle growth, as well as for the regeneration and
repair of injured muscle. Under normal circumstances,
satellite cells are quiescent, but in response to stress, they
are activated, prompting multiple rounds of proliferation
and the expression of myogenic markers.2 Some satellite
cells fuse with one another to form myotubes, whereas
others serve as bridges between myofibers, aiding in their
regeneration.3,4
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Although the exact quantity of satellite cells within
skeletal muscle is dependent on muscle fiber type, ani-
mal age, and species,5 the number of quiescent satellite
cells essentially remains stable within adults over mul-
tiple cycles of injury and regeneration.6 The absolute
number of satellite cells decreases with pathologic states,
including Duchenne muscular dystrophy and chronic
muscle denervation,7–9 as well as with normal physio-
logic decline, such as the onset of advanced age.10 In ad-
dition, satellite cell doubling potential has been demon-
strated to be markedly diminished in Duchenne muscular
dystrophy,11 experimental models of unloading-induced
skeletal muscle atrophy,12,13 and old age.14 With these
conditions, skeletal muscle contractile function signifi-
cantly worsens. It is conceivable that satellite cell deple-
tion promotes this, as the ability to form new myofibers
or repair existing ones is markedly impaired.
Satellite cell depletion secondary
to aging
Numerous investigators have demonstrated that, with
advancing age, skeletal muscle regenerative capacity
diminishes.15–17 One popular explanation for this is that
a decrease in both satellite cell numbers and prolifera-
tive capacity leads to a diminution in skeletal muscle’s
ability to regenerate. Rodent models support this theory,
as a significant decrease in the satellite cell population,
from 4.6% of all cells at 8 months of age to 2.4% at
30 months of age, has been found in the murine soleus
muscle.10 In addition, a substantial impairment in the
proliferative potential, or the number of doublings cul-
tured myoblasts can undergo exists with increasing age.14
Human skeletal muscle, however, does not demonstrate
the same decline in satellite cell numbers with increasing
age.18 In addition, humans fail to demonstrate a differ-
ence in the proliferative potential of satellite cells derived
from children aged 9 years and those isolated from adults
greater than 60 years of age.19 Thus, it is apparent that the
impaired skeletal muscle regenerative response seen with
aging in humans likely results from more factors than just
declining satellite cell numbers and proliferative capacity.
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Apoptosis is a candidate mechanism for satellite cell
depletion in aged animals after injury, thereby contribut-
ing to an impaired skeletal muscle regenerative response.
Satellite cells derived from young and adult rodents, and
subsequently expanded in vitro, demonstrate significantly
diminished percentages of cells with activated caspases
and with fragmented DNA as demonstrated by terminal
deoxynucleotydil transferase-mediated dUTP nick end la-
beling (TUNEL) compared to those from old animals af-
ter being subjected to a pro-apoptotic milieu via incu-
bation with Tumor Necrosis Factor-α and Actinomycin
D.20 In addition, after exposure to the same pro-apoptotic
milieu, satellite cells derived from young and adult rats
demonstrated significantly greater expression of the anti-
apoptotic protein bcl-2 compared to those derived from
old animals.20 These data suggest that aging increases
the satellite cell susceptibility to apoptosis. In old mus-
cle, apoptosis may play a causative role in the depletion of
satellite cells, thereby impairing the regenerative response
to injury.
Factors within the host environment also affect the
regenerative capacity of skeletal muscle, as well as the
satellite cell response to injury. Cross-transplantation of
hindlimb skeletal muscle between 4-month-old and 24-
month-old rats reveals that skeletal muscle from older ro-
dents demonstrates no greater deficit in force-generating
capacity as compared to that from young animals af-
ter transplant-induced and bupivicaine-induced injury;
this is not seen when the muscle is left in its native
environment.21,22 In addition, old animals are less capable
of mounting an immune response, resulting in a decrease
in circulating inflammatory factors and growth factors,23
including Insulin-like Growth Factor-I (IGF-I).24
Inflammatory factors, which include macrophages and as-
sociated cytokines, are critical for normal satellite cell
activation and proliferation.2 Furthermore, IGF-I has
been demonstrated to restore skeletal muscle mass and
satellite cell proliferative potential after multiple cy-
cles of hindlimb loading and unloading,25 as well as
to protect satellite cells from apoptosis.26 It is thus
evident that many variables, including satellite cell
senescence, diminishing satellite cell numbers, increased
satellite cell susceptibility to apoptosis, and changing
factors within the local environment, all contribute
to the impaired regenerative capacity of aged skeletal
muscle.
Satellite cell depletion secondary
to skeletal muscle denervation
Peripheral motor nerve injury results in both skele-
tal muscle atrophy and a permanent deficit in contrac-
tile function.27,28 In response to motor nerve transec-
tion, satellite cells undergo an initial phase of rapid
proliferation.9,29 A prolonged period of denervation, how-
ever, leads to dramatic drop in satellite cell numbers, so
that satellite cells represent approximately 1% of all cells
present within the skeletal muscle cross-section, down
from about 9% in the acute period after denervation.29
This phenomenon begins to occur in the interval 7 weeks
to 20 weeks postdenervation.9 Chronic skeletal mus-
cle denervation has detrimental repercussions, as per-
manent disability results after virtually all such in-
juries, even if neuronal sprouting and regeneration have
occurred.30
The progressive decline in the satellite cell population
may well be the result of programmed satellite cell death.
As early as 2 months after motor nerve transection, a
marked increase in the numbers of nuclei with hypercon-
densed chromatin and fragmented DNA is present dif-
fusely throughout the muscle cross-section.31 Although
most of these apoptotic cells likely represent myonuclei,
it is difficult to assess for satellite cell apoptosis in vivo sec-
ondary to their relative dearth within denervated skeletal
muscle.29 Satellite cells derived from skeletal muscle 6 and
10 weeks after motor nerve transaction and subsequently
exposed to an in vitro proapoptotic milieu demonstrate a
more than twofold increase in percentages of cells with
fragmented DNA and with activated caspases compared
to those isolated from innervated, age-matched control
muscle.32 Although the mechanisms responsible for the
increased satellite cell susceptibility to apoptosis have not
been elucidated, it is reasonable to speculate that the sig-
nals triggering programmed cell death may be related
to either the loss of neuroelectrical stimulation or neu-
rotrophic factors. Interruption of the close relationship
between a nerve and its peripheral target organ leads to cell
death in many different tissues during development.33,34
Although the complex interaction between mature motor
neurons and skeletal muscle is appreciated only at a rudi-
mentary level, end-organ cell death is an almost certain
occurrence after peripheral nerve injury.
Satellite cell depletion with skeletal
muscle atrophy
Sarcopenia, or a reduction in muscle mass, can result from
a number of conditions, some of which are pathologic,
such as denervation, but most of which are physiologic,
including prolonged immobilization, malnutrition and
illness.35 Clinically, sarcopenia can be seen in persons with
prolonged hospitalizations secondary to prolonged illness
or physical frailty. Because of skeletal muscle contractile
dysfunction, these people have an inability to perform
needed activities of daily living, leading to an obviously
diminished quality of life.36 In the laboratory, hindlimb
suspension or skeletal muscle immobilization can be used
to induce physiologic atrophy in rodents.37
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In adolescent rats, hindlimb immobilization irre-
versibly diminishes the numbers of satellite cells and im-
pairs satellite cell proliferative potential within both pre-
dominantly slow-twitch and fast-twitch muscles.12,38 In
contrast, although a decline in satellite cell content is seen
with immobilization of the adult rat hindlimb, remobi-
lization promotes a complete recovery of skeletal muscle
mass and regeneration of myofibers.39,40 This suggests
that, unlike the satellite cells of adolescent rodents, the
satellite cells of adult animals can activate and prolifer-
ate to promote recovery of sarcopenic muscle. In old ro-
dents, a single episode of hindlimb immobilization lasting
10 days leads to a significant loss in skeletal muscle mass
and satellite cell proliferative potential, even when the an-
imal has been permitted 9 weeks recovery time.25 Hence,
although satellite cell proliferative potential is restored
in remobilized skeletal muscle from adult animals, the
same phenomenon is not observed in satellite cells from
adolescent and geriatric animals, both at the extremes of
development.
When IGF-I is infused into the gastrocnemius of old
animals after multiple bouts of atrophy induction by
hindlimb immobilization, the muscle recovers mass and
increases its total protein content. Furthermore, satellite
cells recovered from the muscle experience a significant
increase in proliferative potential.25 This observation sug-
gests that innate deficiencies of satellite cells are not the
sole explanation for satellite cell dysfunction in aged an-
imals and that host factors likely play a crucial role in
satellite cell replicative senescence. The relative contribu-
tions of each factor have yet to be determined.
Satellite cell depletion with exercise
Short bursts of skeletal muscle contraction against high
resistance stimulate muscle hypertrophy.41 Resistance
training, which represents minor skeletal muscle trauma,
generates muscle hypertrophy through the activation of
satellite cells, subsequently followed by satellite cell pro-
liferation, chemotaxis to damaged myofibers, and the fu-
sion of satellite cells to existing myofibers, thereby pro-
moting muscle growth.5 Satellite cell chemotaxis requires
the presence of an intact basal lamina. With resistance
training, or limited myotrauma, no disruption of the basal
lamina occurs, permitting satellite cells to migrate from
their normal position under the basal lamina to the site
of injury.42
In response to exercise-induced trauma to skeletal mus-
cle, an acute inflammatory reaction is evoked, resulting in
a massive influx of macrophages into the injured muscle.
Macrophages are critical in the repair of skeletal muscle,
as they release cytokines and growth factors that control
satellite cell activation and proliferation.43 This is con-
firmed when the appropriate macrophage influx fails to
occur, as a failure of appropriate muscle regeneration is
seen. Similarly, when the macrophage response is intensi-
fied, satellite cell activation is enhanced.44
Resistance training promotes macrophage release of
multiple growth factors, including IGF-I, that promote
satellite cell activation, proliferation, and fusion, ul-
timately leading to muscle hypertrophy.45 Additional
growth factors and cytokines may also promote satel-
lite cell activation, thereby playing a role in the hyper-
trophic response of skeletal muscle to resistance train-
ing, including Hepatocyte Growth Factor, members of
the Fibroblast Growth Factor family, and Leukocyte
Inhibitory Factor;46–48 others, including Transforming
Growth Factor-β and interleukin-6, may inhibit satel-
lite cell proliferation and differentiation.49,50 Although
the complex interplay among the various growth fac-
tors and cytokines in not understood fully, the primary
consequence of repeated, limited myotrauma is satellite
cell activation promoting muscle hypertrophy, and ulti-
mately, skeletal muscle with increased force generating
capacity.2
All movement represents a series of coordinated mus-
cle contractions, in which skeletal muscle either short-
ens, remains constant in length, or stretches while
contracting.51 Significant injury to skeletal muscle fibers
is most likely during those contractions that occur while
activated muscle fibers are stretched, known as length-
ening contractions.52 Although the mechanism by which
lengthening contractions produce myofiber injury is un-
certain, the initial injury is mechanical and focal within
small clusters of sarcomeres.53 This initiates a series of
events, ultimately culminating in secondary injury that
is most severe days after the initial insult.52 At the peak
of injury, as well as having obvious morphologic dam-
age, skeletal muscles from both young and old animals
manifest a deficit in contractile force generating capacity,
though the injury is most severe in the old animals.54,55
In addition to sustaining greater injury compared to that
from younger animals, skeletal muscle from old animals
demonstrates an impaired ability to recover force generat-
ing capacity after contraction-induced injury.16 Although
little data exists regarding the ultimate fate of the satellite
cell population in this scenario, it is reasonable to spec-
ulate that either failure of satellite cell activation or loss
of satellite cells is responsible for the impaired recovery
of skeletal muscle after contraction-induced injury in the
aged population. Unpublished work from our laboratory
reveals that, compared to satellite cells derived from ma-
ture adult rats, a significantly greater percentage of satel-
lite cells derived from aged rats have activated caspases
and have fragmented DNA as demonstrated by TUNEL
after being subjected to an in vitro proapoptotic milieu
(manuscript in preparation; data presented at the 48th
annual Plastic Surgery Research Council, April 25, 2003,
Las Vegas). These findings suggest that increased satellite
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cell apoptosis contributes to the impaired regenerative
capacity of skeletal muscle from old animals after
contraction-induced injury.
Satellite cell depletion with myopathy
The majority of myopathies occur as the result of a muta-
tion affecting cytoskeletal proteins in muscle. Duchenne
muscular dystrophy (DMD), an X-linked recessive dis-
ease affecting primarily skeletal and cardiac muscle, is
the most common deadly genetic disorder in children, af-
fecting nearly 1 in 3500 males worldwide.56 Cardiac and
skeletal muscles lack the protein dystrophin, which serves
as a link between cytoskeletal actin and the extracellular
matrix. This connection is essential for maintaining the
integrity of muscle cell membranes and its absence re-
sults in extremely fragile myofibers.57 The repeated me-
chanical stress brought on by recurring contractions re-
sults in progressive muscle degeneration. The satellite
cell response to the ongoing trauma is to replenish in-
jured skeletal muscle with myofibers lacking dystrophin,
resulting in multiple cycles of muscle degeneration and
regeneration. Ultimately, this exhausts the satellite cell
population.8,58
Patients with DMD begin to manifest symptoms at 4
to 5 years of age, with most boys losing the ability to
walk between 8 to 10 years of age. Progressive respira-
tory insufficiency begins early in the second decade of
life, with death usually occurring in the late teens or early
twenties as the result of respiratory or cardiac failure.59
Using loss of telomere length to quantify the intensity of
muscle cell turnover, it has been demonstrated that skele-
tal muscles derived from dystrophic patients as young
as 4 years old, the age at which clinical symptoms first
become apparent, have already undergone extensive re-
generation; the rate of telomere loss is 14 times greater
than that observed in controls.60 Consistent with this,
the proliferative potential of satellite cells derived from
a 9-year-old dystrophic patient is only one-third of that
of satellite cells harvested from age-matched controls.19
Together, these findings suggest that the diminution of
dystrophic skeletal muscle regenerative capacity is largely
the result of early satellite cell senescence induced by ac-
celerated cycles of muscle degeneration and satellite cell
proliferation.
The host environment within dystrophic skeletal mus-
cle may also contribute to the impaired proliferative po-
tential of satellite cells. Within patients with DMD,
fibroblasts release increased amounts of IGF binding pro-
teins, which sequester IGFs and limit their bioavail-
ability to satellite cells.61 As both IGF-I and IGF-II
are vital in maintaining satellite cell proliferation and
differentiation,62,63 it is probable that limiting their avail-
ability to satellite cells promotes senescence. The IGFs also
likely play a role in the prevention of programmed satel-
lite cell death within skeletal muscle, as they have been
demonstrated to do in vitro with myoblasts.26,64
In the mdx mouse, which lacks dystrophin and provides
an animal model for the study of DMD, degeneration of
dystrophic skeletal muscle largely is the result of necrotic
cell death. Multiple authors have demonstrated, how-
ever, that apoptosis precedes necrosis in some dystrophin-
deficient myofibers of mdx mice, both by TUNEL and
DNA ladder analysis.65–67 Similar findings have been ob-
served in the skeletal muscle of children with DMD, with
as much as 10% of non-necrotic muscle fibers demon-
strating evidence of in situ DNA fragmentation.68 In ad-
dition to myofibers, satellite cells and macrophages with
evidence of DNA fragmentation, suggestive of apopto-
sis, have been identified within the skeletal muscle of
patients with DMD.69 Therefore, although satellite cell
senescence secondary to multiple cycles of muscle degen-
eration and satellite cell proliferation likely plays the pre-
dominant role, increased rates of satellite cell apoptosis
may also promote impaired skeletal muscle regeneration
in patients with DMD.
Future directions
Satellite cells are essential for the normal growth, repair,
and regeneration of adult skeletal muscle. After physi-
ologic degeneration, such as occurs with aging, as well
as with pathologic states, including denervation atrophy
and DMD, satellite cell dysfunction, whether the result of
diminished activation, senescence, or increased apoptosis,
is the principal causes of skeletal muscle’s impaired regen-
erative capacity. What is uncertain, however, is whether
the restoration of satellite cell function can ameliorate
the contractile dysfunction seen in enervated or diseased
skeletal muscle. Although no method yet exists to over-
come normal satellite cell senescence or impaired satellite
cell activation, pharmacologic inhibitors of critical second
messenger systems exist to block apoptosis. It is conceiv-
able that, in the future, therapeutic modalities inhibiting
apoptotic processes may have a role in minimizing the loss
of satellite cells that occurs with physiologic and patho-
logic processes. This may prevent satellite cell depletion
and, because of their requisite role in regenerating and
restoring injured muscle, enhance the regenerative capac-
ity of skeletal muscle.
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